Ann: PTX to resume Clinical Trial of PTX-200 in Ovarian Cancer, page-7

Spot on couz.
This is cheap.
I reckon traders picked this up @ low 5’s to sell on the recent positive announcements, 50% profits in 3 months. Played out well. That’s the call for the pull back on SP in the past week.
I expect this has shaken out the traders.
We’ve consolidated nicely, look to accumulate till years end. 2018 will present many company changing opportunities.
I’ll keep backing this, had temptations to sell when it got to high 7’s the other week but it’s not worth trying to play this, trading way to cheap. I want to grab maybe another 90,000 this month.